By Lilian Massihi, MD, Board-Certified Family Medicine, Advanced BHRT Certification
It usually starts small enough to explain away. A period that runs a day or two longer than it used to. Then one that arrives like a flood, the kind that has you standing up carefully and planning your day around where the bathrooms are. Then a month with nothing at all, followed by two weeks of spotting that never quite becomes anything.
Somewhere in there you mentioned it, and you were told this is what happens before menopause. That is true. It is also not the whole answer, and the distance between those two things is where a lot of women spend a couple of years.
The short answer: Bleeding changes in the years before menopause are extremely common, and the research is unusually specific about how common. They are also one of the most overlooked reasons midlife women feel worn down, because blood loss every month is iron loss every month. And a minority of these bleeding patterns are not hormonal at all, which is why some of them need an evaluation rather than reassurance. This article covers all three: what changes and why, what the bleeding does to your energy, and which patterns should send you to be checked.
Your Cycle Does Not Wind Down Gently. It Gets Erratic First.
The mental model most of us carry is that periods gradually fade out, getting lighter and further apart until they stop. For some women that is how it goes. For many it is the opposite, and the reason is worth understanding, because it explains nearly everything else in this article.
In your thirties, a typical cycle runs on a predictable sequence. Estrogen rises and builds the uterine lining. You ovulate. The follicle you released the egg from then produces progesterone, which stabilizes that lining and holds it in place. When no pregnancy occurs, progesterone falls, and the lining is shed in an organized way over a few days.
In perimenopause, the ovulation step becomes unreliable. Some cycles you ovulate, some you do not. The cycles where you do not are the ones that cause trouble, because estrogen still builds the lining, but without ovulation there is no meaningful progesterone to stabilize it. The lining keeps thickening with nothing holding it together. When it finally goes, it goes all at once.
That is the flooding. It is not a sign that your body has become unpredictable for no reason. It is the mechanical consequence of estrogen acting without its counterweight, and it is the same mechanism that makes the timing so erratic: without ovulation there is no clock setting the length of the second half of your cycle.
How Common This Is, in Actual Numbers
Most articles on this topic say bleeding changes are common and leave it there. There is better data than that, and it comes from women who wrote down what happened every single day.
The Study of Women’s Health Across the Nation ran a menstrual calendar substudy in which 1,320 midlife women kept daily records from 1996 to 2006. Over about ten and a half years of observation, the researchers counted how many women had repeated episodes of each bleeding pattern. Having at least three separate episodes of a period lasting ten days or longer happened to 77.7 percent of them. At least three episodes of six or more days of spotting happened to 66.8 percent. At least three episodes that included three or more days of genuinely heavy flow happened to 34.5 percent.
So roughly one in three women in that group had repeated stretches of heavy bleeding, and more than three quarters had repeated stretches of prolonged bleeding. If your periods have changed character in your forties, you are not an outlier and you are not describing something unusual.
What that data does not tell you is whether any particular episode is hormonal or structural. That is a separate question, and it is the one the rest of this article is really about.
The Part Almost Nobody Connects: Bleeding and Exhaustion
Here is the finding that changed how I ask about this in a first visit.
In March 2025, researchers using that same SWAN cohort published the first study designed to look at whether heavy and prolonged bleeding is connected to the fatigue women report during the transition. They followed 2,329 women who kept menstrual diaries and answered questions about their energy at seven annual visits.
Women who recorded three or more episodes of heavy bleeding in the previous six months had meaningfully higher odds of reporting that they felt tired, an odds ratio of 1.62 with a confidence interval from 1.11 to 2.38. Women with three or more episodes of prolonged bleeding were less likely to describe themselves as full of pep, an odds ratio of 0.68 with a confidence interval from 0.49 to 0.95.
The reason those numbers matter more than they look is what the researchers adjusted for. The models accounted for age, body mass index, hormone therapy use, depressive symptoms, anxiety symptoms, perceived stress, sleep problems, smoking, race and ethnicity, and experiences of discrimination. In other words, the link between bleeding and fatigue was still there after accounting for poor sleep and low mood, which are the two explanations midlife fatigue usually gets handed.
I want to be accurate about the limits here. A third measure the study looked at, feeling worn out, moved in the same direction but did not reach statistical significance, and the study design shows an association rather than proving cause. But the mechanism is not mysterious. Blood carries iron. Losing more blood every month means losing more iron every month, and iron deficiency makes people tired long before it is severe enough to be called anemia.
The practical consequence is simple and it gets missed constantly. If you are bleeding heavily and you are exhausted, those are probably not two separate problems to be managed separately. Fatigue in this decade of life gets attributed to the transition in general, to broken sleep, or to a thyroid result someone glanced at. All three are real causes. Iron loss from heavy periods belongs on that list, and a ferritin level is not an exotic test.
Which Bleeding Needs to Be Looked At
This is the section that matters most, so I am going to be direct.
Not every heavy period in your forties is hormonal. Fibroids are common, reported in up to 80 percent of women by age 50, and while most cause no symptoms at all, the ones positioned near the uterine lining are a frequent cause of heavy bleeding. Polyps can do the same. Adenomyosis can. And the same unopposed estrogen that causes the flooding can, over time, drive the lining to overgrow, a condition called endometrial hyperplasia, which in some cases can progress toward endometrial cancer.
That last sentence is the reason this article exists in the form it does. Endometrial cancer is the most common cancer of the female reproductive system, and abnormal bleeding is its most common early sign. Caught early, the outlook is good. The danger is not the symptom. The danger is a year of the symptom being filed under the transition.
The American College of Obstetricians and Gynecologists publishes a patient list of bleeding that should not be dismissed as part of the transition. Their list includes bleeding or spotting between periods, bleeding or spotting after sex, heavy bleeding during a period, bleeding that is heavier or lasts more days than it used to, and any bleeding at all after menopause has been reached.
A few things worth adding to that list from a practical standpoint. Soaking through a pad or tampon every hour for several hours in a row, passing clots larger than a quarter, bleeding that lasts more than seven or eight days, or bleeding heavy enough to make you lightheaded all deserve prompt attention. Bleeding after a full year without periods is the one that should never wait, whatever your age and however light it is.
What an Evaluation Actually Involves
I am going to say something here that may seem odd coming from a hormone practice.
If your bleeding fits any of the patterns above, the first step is not a hormone panel. It is a gynecologic evaluation, in person, with an exam. That typically means a pelvic ultrasound to look at the uterus and the thickness of the lining, and often an endometrial biopsy, a brief office procedure that samples the lining so it can be examined under a microscope. Depending on what those show, a saline ultrasound or a hysteroscopy may be used to look inside the uterus directly.
Those are the tests that separate a structural cause from a hormonal one, and no blood test substitutes for them. Gynecologists organize the possible causes with a framework that splits them into structural findings that can be seen on imaging, such as polyps, adenomyosis, fibroids and malignancy, and non-structural ones, such as ovulatory dysfunction, clotting disorders and medication effects. Perimenopausal anovulation sits in that second group, which means it is partly a diagnosis you reach by ruling out the first group.
What a hormone-focused evaluation adds, once structural causes have been addressed or excluded, is the other half of the picture: where you actually are in the transition, what your iron stores look like after months of heavier losses, what your thyroid is doing, and whether the symptoms stacked on top of the bleeding share a cause. That is the work of hormone optimization, and it is genuinely useful work. It is just not the first thing that should happen when the presenting symptom is abnormal bleeding.
I would rather tell you that plainly than have you spend three months on the wrong kind of appointment.
Where Hormone Therapy Fits, and Where It Does Not
Progesterone is the hormone missing from an anovulatory cycle, and it is the one that stabilizes the uterine lining. That is why progestogen therapy is a recognized part of managing bleeding driven by ovulatory dysfunction, and why endometrial hyperplasia caused by too much estrogen relative to progesterone is often addressed with progestin therapy. The logic follows directly from the mechanism described at the top of this article.
What I will not tell you is that hormone therapy is the answer to heavy bleeding, because that depends entirely on what is causing it. It will not shrink a fibroid that is distorting the uterine cavity. It does not substitute for finding out what is there. And any decision about hormones when abnormal bleeding is in the picture is a decision that has to be made with the evaluation results in hand, not ahead of them.
That distinction is not a caveat added at the end. It is the whole point. A practice that offers to solve your bleeding before anyone has looked is not being confident, it is skipping a step. If you are weighing where to take this, our approach to the menopause transition is built around sequencing it in the right order: find out what is actually happening, then decide what to do about it, then keep measuring.
Frequently Asked Questions
How heavy is too heavy?
The practical thresholds are soaking through a pad or tampon every hour for several consecutive hours, passing clots larger than a quarter, needing to double up on protection, or bleeding that lasts longer than seven or eight days. ACOG describes a typical period as lasting up to eight days. Any of those patterns is worth an appointment, and bleeding heavy enough to leave you lightheaded should be seen promptly.
Can heavy periods actually be the reason I am so tired?
They can contribute, and there is now direct evidence for it. A 2025 analysis of 2,329 women in the SWAN cohort found that repeated episodes of heavy bleeding were associated with higher odds of feeling tired, and the association held after adjusting for sleep problems, mood and stress. The likely pathway is iron loss, and iron deficiency causes fatigue well before it becomes anemia. Ask for a ferritin level, not just a hemoglobin.
Why did my periods get heavier instead of lighter?
Because ovulation becomes unreliable before it stops. In cycles where you do not ovulate, estrogen builds the uterine lining but there is little progesterone to stabilize it, so the lining thickens and then sheds all at once. Heavier, longer and more erratic periods are a common pattern in the transition rather than an unexpected one.
Do I need a biopsy?
That is a decision for the clinician doing the evaluation, based on your age, your bleeding pattern, your risk factors and what the ultrasound shows. An endometrial biopsy is a short office procedure that samples the uterine lining. It is the test that distinguishes benign overgrowth from hyperplasia and from cancer, which is why it is used often in this age group.
I already went through menopause and I am spotting. Does that count?
Yes, and it is the one pattern in this article that should not wait. Any bleeding after twelve consecutive months without a period needs evaluation, even if it is a single episode and even if it is light. Most causes turn out to be benign. The reason for the urgency is that this is also the earliest sign of endometrial cancer, and early is when the outlook is best.
Can I just track it and see if it settles down?
Tracking is genuinely useful, and bringing a few months of records to an appointment makes the conversation far more productive. But tracking is a supplement to an evaluation, not a substitute for one. If your bleeding fits any of the patterns above, log it and get it looked at rather than logging it and waiting.
AllureMD is a physician-led hormone optimization practice in Madison, Mississippi. If bleeding changes are part of what brought you here, the right first step is a gynecologic evaluation, and we will tell you so. For the rest of the picture, the fatigue, the iron, the thyroid, and where you actually are in the transition, Lilian Massihi, MD evaluates each patient’s complete hormonal picture before making any recommendation. To schedule your consultation, book a complimentary discovery call.
About the Author
Lilian Massihi, MD is a board-certified family medicine physician and hormone optimization specialist who completed her undergraduate education at UCLA, earned her medical degree at the University of Poznań, and finished her residency at the University of Mississippi Medical Center. For more than five years, she practiced as a hospitalist, treating patients in the late stages of cardiovascular disease, cognitive decline, and severe osteoporosis. She kept asking the same question: what would have been different if someone had intervened sooner? That question led her to bioidentical hormone therapy, where a rigorous review of the evidence changed the direction of her career. She founded AllureMD in Madison, Mississippi to practice the kind of medicine she had come to believe in: treating the entire hormonal system, titrating to how patients actually feel, with a physician leading every decision.